Skip to main content

Table 1 Clinical and plasma parameters of the study population

From: Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study

 

All individuals

Individuals without type 2 diabetes and NASH

Type 2 diabetes patients

NASH patients

Individuals with type 2 diabetes and NASH

 

No. of individuals/Mean (SD)

Minimal/maximal values

No. of individuals/Mean (SD)

Minimal/maximal values

No. of individuals/Mean (SD)

Minimal/maximal values

No. of individuals/Mean (SD)

Minimal/maximal values

No. of individuals/Mean (SD)

Minimal/maximal values

Number of individuals

75

 

29

 

25

 

41

 

20

 

Male/female

22/53

 

7/22

 

7/18

 

12/29

 

4/16

 

Age (years)

44.4 (9.9)

17 - 67

40.3 (9.2)

17 - 54

48.2 (9.4)

28 - 67

45.8 (8.9)

28 - 65

46.5 (8.1)

28 - 65

BMI (kg/m2)

46.5 (9.6)

34.6 - 73.6

42.6 (6.5)

34.6 - 56.8

49.4 (11.4)

34.8 - 73.6

48.7 (10.8)

34.8 - 73.6

49.6 (12.1)

34.8 - 73.6

Glucose (mmol/l)

6.60 (2.1)

4.3 - 14.5

5.53 (0.49)

4.3 - 6.5

8.73 (2.5)

4.3 - 14.5

7.16 (2.56)

4.3 - 14.5

8.8 (2.72)

4.3 - 14.5

Insulin (mU/l)

19.3 (10.9)

3.8 - 53

16.7 (8.8)

5.6 - 37

20.6 (13.1)

5.5 - 53

20.9 (11.1)

3.8 - 49

20.4 (10.9)

3.8 - 49

HbA1c

6.58 (1.39)

5.1 - 12.1

6 (0.54)

5.1 - 7.2

7.9 (1.78)

5.3 - 12.1

6.88 (1.65)

5.2 - 12.1

7.85 (1.88)

5.2 - 12.1

Total cholesterol (mmol/l)

5.08 (1.1)

3 - 9.8

4.93 (0.65)

3.5 - 6.1

5.15 (1.43)

3.5 - 9.8

5.08 (1.23)

3 - 9.8

5.2 (1.5)

3 - 9.8

HDL cholesterol (mmol/l)

0.98 (0.38)

0.5 - 2.8

1.05 (0.3)

0.6 - 1.9

0.8 (0.23)

0.5 - 1.3

0.93 (0.44)

0.5 - 2.8

0.78 (0.22)

0.5 - 2.8

LDL cholesterol (mmol/l)

3.22 (1.02)

1.1 - 7.4

3.16 (0.86)

1.1 - 4.3

3.29 (1.18)

1.5 - 7.4

3.17 (1.06)

1.5 - 7.4

3.32 (1.25)

1.5 - 7.4

TG (mmol/l)

2.26 (2.12)

0.63 - 16.4

1.67 (0.95)

0.63 - 4.2

3.31 (3.46)

0.88 - 16.4

2.73 (2.71)

0.88 - 16.4

3.56 (3.67)

0.88 - 16.4

NEFA (mmol/l)

0.64 (0.32)

0.12 - 1.66

0.52 (0.34)

0.12 - 1.66

0.72 (0.3)

0.16 - 1.33

0.71 (0.28)

0.21 - 1.33

0.76 (0.29)

0.21 - 1.33

ALAT (U/l)

25.7 (16.5)

6 - 124

19.8 (6.3)

7 - 37

32.3 (23.1)

10 - 124

27.7 (19.3)

6 - 124

32.4 (24.8)

6 - 124

ASAT (U/l)

25.3 (12.9)

7 - 72

21.1 (11.6)

7 - 50

28.9 (15.4)

8 - 72

28.4 (13)

8 - 72

30.7 (16)

8 - 72

CRP (mg/l)

10.2 (8.5)

1 - 37

9.9 (9.2)

1 - 37

13.1 (10)

1.7 - 35

10 (8.2)

1.7 - 35

12.8 (10.2)

1.7 - 35

  1. Data are means ± standard deviation (SD) and the minimal and maximal values for each trait. Data are given for all individuals, individuals without type 2 diabetes or NASH, type 2 diabetes patients, NASH patients, and individuals with both type 2 diabetes and NASH. Patients with type 2 diabetes are 36, 37, 40, 42, 43, 49, 51, 54, 55, 57, 60, 63, 64, 65, 69, 75, 77, 78, 79, 85, 87, 97, 101, 103, and 110 - IDs are concordant with the IDs used submitted to the Gene Expression Omnibus database. Patients with NASH are 38, 42, 43, 44, 45, 47, 49, 51, 52, 53, 54, 57, 58, 60, 62, 63, 64, 65, 69, 72, 75, 78, 79, 83, 85, 87, 88, 92, 93, 95, 97, 99, 100, 101, 102, 103, 104, 105, 107, 110, and 113. TG, triglycerides; NEFA, non-esterified fatty acid; ALAT, alanine aminotransaminase; ASAT, aspartate aminotransaminase; CRP, C-reactive protein; NASH, non-alcoholic steatohepatitis.
Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us